MedTrace Logo

Mindfulness-based Virtual Reality Intervention

NCT05602051 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-11-01

No results posted yet for this study

Summary

Through virtual reality technology and mindfulness therapy, we can intervene the patients with Hematologic Neoplasms during chemotherapy, hoping to improve their symptoms and self-efficacy.

Conditions

  • Hematologic Neoplasms

Interventions

DEVICE

virtual reality device

mindfulness combined with virtual reality

Sponsors & Collaborators

  • Nanjing University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • yuxi Zhang · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05602051 on ClinicalTrials.gov